ArticleFrontiers in pharmacology2021

Resveratrol and Angiogenin-2 Combined With PEGDA/TCS Hydrogel for the Targeted Therapy of Hypoxic Bone Defects via Activation of the Autophagy Pathway.

Dehui Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.